Breaking satellite silence: human satellite II RNA expression in ovarian cancer

por Ganesan, Shridar
Publicado 2022

Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer

por Panda, Anshuman, Ganesan, Shridar
Publicado 2021

Emerging strategies for treating metastasis

por Esposito, Mark, Ganesan, Shridar, Kang, Yibin
Publicado 2021

A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade

por Panda, Anshuman, Betigeri, Anil, Ganesan, Shridar
Publicado 2022

Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma

por Panda, Anshuman, Bhanot, Gyan, Ganesan, Shridar, Bajpai, Manisha
Publicado 2021

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment

por Rojas, Veronica, Hirshfield, Kim M., Ganesan, Shridar, Rodriguez-Rodriguez, Lorna
Publicado 2016

Integrating phosphoproteomics into the clinical management of prostate cancer

por Cheng, Larry C., Tan, Victor M., Ganesan, Shridar, Drake, Justin M.
Publicado 2017

Nuclear topology modulates the mutational landscapes of cancer genomes

por Smith, Kyle S., Liu, Lin L., Ganesan, Shridar, Michor, Franziska, De, Subhajyoti
Publicado 2017

Genomic and immunologic correlates of LAG-3 expression in cancer

por Panda, Anshuman, Rosenfeld, Jeffrey A., Singer, Eric A., Bhanot, Gyan, Ganesan, Shridar
Publicado 2020

Targetable alterations in invasive pleomorphic lobular carcinoma of the breast

por Riedlinger, Gregory M., Joshi, Sonali, Hirshfield, Kim M., Barnard, Nicola, Ganesan, Shridar
Publicado 2021

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

por George, Mridula A., Qureshi, Sadaf, Omene, Coral, Toppmeyer, Deborah L., Ganesan, Shridar
Publicado 2021

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker

por Qureshi, Sadaf, Chan, Nancy, George, Mridula, Ganesan, Shridar, Toppmeyer, Deborah, Omene, Coral
Publicado 2022

Role of Biomarkers in the Development of PARP Inhibitors

por Ganguly, Bratati, Dolfi, Sonia C., Rodriguez-Rodriguez, Lorna, Ganesan, Shridar, Hirshfield, Kim M.
Publicado 2016

Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine

por Morgan, Katherine M., Riedlinger, Gregory M., Rosenfeld, Jeffrey, Ganesan, Shridar, Pine, Sharon R.
Publicado 2017

Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis

por Popli, Pallvi, Gutterman, Elane M., Omene, Coral, Ganesan, Shridar, Mills, Douglas, Marlink, Richard
Publicado 2021

Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX

por Basavanhally, Ajay, Feldman, Michael, Shih, Natalie, Mies, Carolyn, Tomaszewski, John, Ganesan, Shridar, Madabhushi, Anant
Publicado 2012

Computer-assisted assessment of the Human Epidermal Growth Factor Receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quanti...

por Hall, Bonnie H, Ianosi-Irimie, Monica, Javidian, Parisa, Chen, Wenjin, Ganesan, Shridar, Foran, David J
Publicado 2008

Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers

por Paratala, Bhavna S., Dolfi, Sonia C., Khiabanian, Hossein, Rodriguez-Rodriguez, Lorna, Ganesan, Shridar, Hirshfield, Kim M.
Publicado 2016

Portraits of breast cancer progression

por Dalgin, Gul S, Alexe, Gabriela, Scanfeld, Daniel, Tamayo, Pablo, Mesirov, Jill P, Ganesan, Shridar, DeLisi, Charles, Bhanot, Gyan
Publicado 2007

Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance

por Anantha, Rachel W, Simhadri, Srilatha, Foo, Tzeh Keong, Miao, Susanna, Liu, Jingmei, Shen, Zhiyuan, Ganesan, Shridar, Xia, Bing
Publicado 2017